Showing Results for
- Academic Journals (11)
Search Results
- 11
Academic Journals
- 11
- Search Terms:
- 1From: Bone Marrow Transplantation. (Vol. 44, Issue 12) Peer-ReviewedAnogenital human papillomavirus (HPV) is a common sexually transmitted infection and is associated with cutaneous manifestations varying from inapparent infections to genital warts, condylomata accuminata and different...
- 2From: Bone Marrow Transplantation. (Vol. 44, Issue 12) Peer-ReviewedThe optimal timing for recombinant human (rh)G-CSF administration after chemotherapy for PBSC mobilization has not yet been determined. In this study, we compared two different time schedules of rhG-CSF; 4th (early) vs...
- 3From: Bone Marrow Transplantation. (Vol. 44, Issue 12) Peer-ReviewedWe retrospectively analyzed the characteristics of 16 consecutive pediatric patients who received one or more G-CSF-mobilized donor lymphocyte infusions (DLI) following a T-cell-depleted haplocompatible hematopoietic...
- 4From: Bone Marrow Transplantation. (Vol. 44, Issue 12) Peer-ReviewedIron overload is known to increase complications of hematopoietic SCT (HSCT). We investigated the association of pre-transplant ferritin level with complications and survival after allogeneic HSCT, and evaluated the...
- 5From: Bone Marrow Transplantation. (Vol. 44, Issue 12) Peer-ReviewedOne of the obstacles to chronic GVHD research is the lack of standardized response criteria. The National Institute of Health (NIH) has recommended response criteria at a Consensus Conference. These need to be...
- 6From: Bone Marrow Transplantation. (Vol. 44, Issue 12) Peer-ReviewedGVHD is artificially divided into acute and chronic forms depending on its date of onset. Although there may be a continuum of clinical findings, chronic GVHD can affect numerous organs that are not typically affected...
- 7From: Bone Marrow Transplantation. (Vol. 44, Issue 12) Peer-ReviewedA 40-year-old white man was diagnosed with precursor B-cell acute lymphoblastic leukemia (ALL) in December 2004 that was refractory to at least three reinduction attempts. BM aspiration and biopsy immediately before...
- 8From: Bone Marrow Transplantation. (Vol. 44, Issue 12) Peer-ReviewedIn this prospective study, we examined the toxicity and efficacy of an intensified conditioning regimen for treatment of patients with relapsed or high-risk acute lymphoblastic leukemia who undergo allogeneic...
- 9From: Bone Marrow Transplantation. (Vol. 44, Issue 12) Peer-ReviewedAfter allogeneic haematopoietic SCT (HSCT), opportunistic infections still remain one of the major complications. (1-3) At present, advances in therapeutic modalities make HSCT available for elderly patients and...
- 10From: Bone Marrow Transplantation. (Vol. 44, Issue 12) Peer-ReviewedRelapse after allo-SCT for AML carries very poor prognosis. Second allo-SCT, although curative, is not an appropriate treatment option for a large number of relapsing patients (only 2-20% patients receive a second...
- 11From: Bone Marrow Transplantation. (Vol. 44, Issue 12) Peer-ReviewedWe earlier published data on 136 children who received hematopoietic SCT (HSCT) for ALL, and showed that early lymphocyte recovery is a powerful indicator for survival by GVL effect without increase in GVHD. To answer...